Search Results - "Ahmad, Laura"

The Case of the Passive Activist by Ahmad, Laura

Get full text

The Orthogeriatrics Model of Care: Systematic Review of Predictors of Institutionalization and Mortality in Post-Hip Fracture Patients and Evidence for Interventions by Martinez-Reig, Marta, MD, Ahmad, Laura, MD, PhD, FRACP, Duque, Gustavo, MD, PhD, FRACP

“…Abstract Hip fracture is a common serious complication of osteoporosis, which is associated with high morbidity and mortality. In nursing home residents,…”
Get full text

Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors by Bymaster, Frank P., Dreshfield-Ahmad, Laura J., Threlkeld, Penny G., Shaw, Janice L., Thompson, Linda, Nelson, David L., Hemrick-Luecke, Susan K., Wong, David T.

“…The blockade of serotonin (5-HT) and norepinephrine (NE) transporters in vitro and in vivo by the dual 5-HT/NE reuptake inhibitors duloxetine and venlafaxine…”
Get full text

Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4 by ROCCO, Vincent P, SPINAZZE, Patrick G, TAKEUCHI, Kumiko, KOHN, Todd J, HONIGSCHMIDT, Nicholas A, NELSON, David L, WAINSCOTT, D. Bradley, AHMAD, Laura J, SHAW, Janice, THRELKELD, Penny G, WONG, David T

“…A series of 1-(1H-indol-4-yloxy)-3-(4-arylpiperidinyl)propan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was…”
Get full text

Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1 by TAKEUCHI, Kumiko, KOHN, Todd J, THRELKELD, Penny G, WONG, David T, HONIGSCHMIDT, Nicholas A, ROCCO, Vincent P, SPINAZZE, Patrick G, KOCH, Daniel J, NELSON, David L, WAINSCOTT, D. Bradley, AHMAD, Laura J, SHAW, Janice

“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text

Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3 by TAKEUCHI, Kumiko, KOHN, Todd J, SHAW, Janice, THRELKELD, Penny G, WONG, David T, HONIGSCHMIDT, Nicholas A, ROCCO, Vincent P, SPINAZZE, Patrick G, ATKINSON, Steven T, HERTEL, Larry W, NELSON, David L, WAINSCOTT, D. Bradley, AHMAD, Laura J

“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2 by TAKEUCHI, Kumiko, KOHN, Todd J, AHMAD, Laura J, SHAW, Janice, THRELKELD, Penny G, WONG, David T, HONIGSCHMIDT, Nicholas A, ROCCO, Vincent P, SPINAZZE, Patrick G, KOCH, Daniel J, ATKINSON, Steven T, HERTEL, Larry W, NELSON, David L, WAINSCOTT, D. Bradley

Get full text

Orthogeriatric services associated with lower 30‐day mortality for older patients who undergo surgery for hip fracture by Zeltzer, Justin, Mitchell, Rebecca J, Toson, Barbara, Harris, Ian A, Ahmad, Laura, Close, Jacqui

“…Objective: To examine the impact of orthogeriatric services on 30‐day mortality and length of stay (LOS) for hip fracture patients undergoing surgery in public…”
Get full text

Amiodarone in the aged by Srinivasan, Meera, Ahmad, Laura, Bhindi, Ravinay, Allahwala, Usaid

“…Amiodarone is a highly effective antiarrhythmic drug, but can have serious adverse effects, particularly in older patients. If possible it should not be used…”
Get full text

Position statement: a clinical approach to the management of adult non‐neurogenic overactive bladder by Chung, Eric, Lee, Dominic, Gani, Johan, Gillman, Michael, Maher, Christopher, Brennan, Janelle, Johns Putra, Lydia, Ahmad, Laura, Chan, Lewis LW

“…Summary Introduction: Overactive bladder (OAB) is a highly prevalent medical condition that has an adverse impact on various health‐related quality‐of‐life…”
Get full text

Do informal interviews improve medical student empathy with the elderly? by Ahmad, Laura, Sawley, Enid, Creasey, Helen

Get full text

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine by Rasmussen, K, Calligaro, D O, Czachura, J F, Dreshfield-Ahmad, L J, Evans, D C, Hemrick-Luecke, S K, Kallman, M J, Kendrick, W T, Leander, J D, Nelson, D L, Overshiner, C D, Wainscott, D B, Wolff, M C, Wong, D T, Branchek, T A, Zgombick, J M, Xu, Y C

“…LY426965 [(2S)-(+)-1-cyclohexyl-4-[4-(2-methoxyphenyl)-1-piperazinyl]2-methyl- 2-phenyl-1-butanone monohydrochloride] is a novel compound with high affinity…”
Get more information

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT 1A receptor antagonism/SSRI activities. Part 4 by Rocco, Vincent P., Spinazze, Patrick G., Kohn, Todd J., Honigschmidt, Nicholas A., Nelson, David L., Bradley Wainscott, D., Ahmad, Laura J., Shaw, Janice, Threlkeld, Penny G., Wong, David T., Takeuchi, Kumiko

“…A series of 1-(1 H-indol-4-yloxy)-3-(4-arylpiperidinyl)propan-2-ols possessing potent dual 5-HT 1A receptor antagonism and serotonin reuptake inhibition was…”
Get full text

Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2 by Takeuchi, Kumiko, Kohn, Todd J, Honigschmidt, Nicholas A, Rocco, Vincent P, Spinazze, Patrick G, Koch, Daniel J, Atkinson, Steven T, Hertel, Larry W, Nelson, David L, Wainscott, D Bradley, Ahmad, Laura J, Shaw, Janice, Threlkeld, Penny G, Wong, David T

“…Potent 5-HT1A/SSRIs at low nanomolar and subnanomolar concentrations were identified in a series of…”
Get full text

Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT 1A receptor antagonism/SSRI activities. Part 2 by Takeuchi, Kumiko, Kohn, Todd J, Honigschmidt, Nicholas A, Rocco, Vincent P, Spinazze, Patrick G, Koch, Daniel J, Atkinson, Steven T, Hertel, Larry W, Nelson, David L, Wainscott, D.Bradley, Ahmad, Laura J, Shaw, Janice, Threlkeld, Penny G, Wong, David T

“…Potent 5-HT1A/SSRIs at low nanomolar and subnanomolar concentrations were identified in a series of 1-(1 H-indol-4-yloxy)-3-(4-benzo[…”
Get full text

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT 1A receptor antagonism/SSRI activities. Part 1 by Takeuchi, Kumiko, Kohn, Todd J, Honigschmidt, Nicholas A, Rocco, Vincent P, Spinazze, Patrick G, Koch, Daniel J, Nelson, David L, Wainscott, D.Bradley, Ahmad, Laura J, Shaw, Janice, Threlkeld, Penny G, Wong, David T

“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT 1A receptor antagonism and serotonin reuptake inhibition was discovered. 1-(1…”
Get full text

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT 1A receptor antagonism/SSRI activities. Part 3 by Takeuchi, Kumiko, Kohn, Todd J, Honigschmidt, Nicholas A, Rocco, Vincent P, Spinazze, Patrick G, Atkinson, Steven T, Hertel, Larry W, Nelson, David L, Wainscott, D.Bradley, Ahmad, Laura J, Shaw, Janice, Threlkeld, Penny G, Wong, David T

“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT 1A receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text

Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of way 100635 and fluoxetine by Dreshfield-Ahmad, Laura J., Thompson, Dennis C., Schaus, John M., Wong, David T.

“…It has been demonstrated that synthesis of serotonin (5-HT) is dependent on the availability of precursor, as well as the activity of 5-HT neurons. In the…”
Get full text

Bad Pharma: How drug companies mislead doctors and harm patients by Ahmed, Laura

Get full text

Outcomes and Costs After Hip Fracture and Stroke: A Comparison of Rehabilitation Settings by Kramer, Andrew M, Steiner, John F, Schlenker, Robert E, Eilertsen, Theresa B, Hrincevich, Carol A, Tropea, Daryl A, Ahmad, Laura A, Eckhoff, Donald G

“…Objective.—To assess whether outcomes and costs differ for elderly patients admitted to rehabilitation hospitals, subacute nursing homes, and traditional…”
Get full text